Drugs to treat overactive bladder don't work very well, according to a recent CR Best Buy Drugs analysis. Studies have found that only a small proportion of people get full relief of their ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Coping with overactive bladder -- away or at home -- is in your hands. Between lifestyle changes, exercises, medication and perhaps even surgery, you can manage -- or even prevent -- overactive ...

The standard treatments for overactive bladder include lifestyle changes, bladder training, pelvic floor muscle training and anticholinergic (anti-muscarinic) drugs. Additional treatments for some ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in ...

This is called an Overactive Bladder ... mostly with the history and a “bladder diary” where you will be asked to keep a note of your fluid intake over a period of 24 - 72 hours.

An important question is how PTNS compares with the established alternatives for the treatment of overactive bladder ... a mean of 12.1 ± 4.9 treatments over 263 days. At six and 12 months ...